A major discovery in cancer investigation is emerging with the use of nanobodies to reactivate damaged p53. This crucial tumor inhibitor protein is frequently inactivated in various types of malignancies, resulting https://bookmarkrange.com/story23891144/mini-antibodies-reactivate-p53-new-potential-pathway-for-cancer-therapy